Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment

Clin Lymphoma Myeloma Leuk. 2021 May;21(5):e456-e459. doi: 10.1016/j.clml.2020.12.022. Epub 2020 Dec 26.

Affiliations

¹ Division of Hematology, Azienda Ospedaliero Universitaria Policlinico-Vittorio Emanuele Catania, Catania, Italy. Electronic address: bellofioreclaudia@gmail.com.
² Division of Hematology, Azienda Ospedaliero Universitaria Policlinico-Vittorio Emanuele Catania, Catania, Italy.
³ Division of Cardiology, Azienda Ospedaliero Universitaria Policlinico-Vittorio Emanuele Catania, Catania, Italy.

PMID: 33531286
DOI: 10.1016/j.clml.2020.12.022

No abstract available

Keywords: Cardiovascular adverse events; Heart arrhythmias; Immunomodulatory drugs; Monoclonal gammopathy; Plasma-cell disorders.

Publication types

Case Reports

MeSH terms

Adult
Brugada Syndrome / drug therapy*
Brugada Syndrome / etiology*
Brugada Syndrome / pathology
Humans
Lenalidomide / pharmacology
Lenalidomide / therapeutic use*
Male
Multiple Myeloma / complications*

Substances

Lenalidomide